Symptom Burden
Symptom Burden - Related Videos
02:03
Assessing Bacterial Burden in the Mouse Spleen for Infection Studies
0 Views •
2026
Source: Madenspacher, J. H. and Fessler, M. B. A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice. J. Vis. Exp. (2016)This video demonstrates the process of quantifying bacterial load in the spleen of an infected mouse to assess the severity of infection. The homogenized spleen is serially diluted and plated to determine total bacterial burden. The resulting data provide insights into host-pathogen interactions within...
04:02
Neurostimulation System Setup and Symptom Collection for Personalized Treatment of Depression
0 Views •
2025
Source: Sellers, K. K. et al. Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder. J. Vis. Exp. (2023)This video demonstrates the procedure for system setup and data recording to support patient-specific biomarker detection and neurostimulation delivery for treating major depressive disorder.
03:23
Measurement of the In Vivo Burden of Bacteria Expressing Luciferase in an Insect Larva
0 Views •
2025
This video showcases the in vivo bacterial burden measurement using Bacillus Calmette-Guérin, BCG, lux-infected insect larvae. The process involves larval homogenization, treatment with a luciferase substrate, and bioluminescence measurement to determine relative light units that correlate with bacterial burden.
03:46
Malassezia-Induced Skin Inflammation and Fungal Burden Analysis in a Murine Model
0 Views •
2025
This video demonstrates Malassezia-induced skin infection in mice. Malassezia oil suspension is applied over the wounded ear, triggering inflammation and swelling of the ear tissue. Later, the ears are dissected, homogenized, and spread on an agar plate for growth. The number of colonies indicates the fungal burden resulting from skin inflammation.
04:29
Monitoring Neutrophil Recruitment Dynamics and Bacterial Burden at the Infection Site in a Murine Model
0 Views •
2025
This video demonstrates in vivo imaging to study the neutrophil recruitment dynamics at an infection site in an immunocompromised, transgenic mouse with GFP-expressing neutrophils. It involves injecting luminescent bacteria to cause an infection. This leads to neutrophil recruitment to the infection site, whose tracking is done by imaging.
FAQs
Assessment becomes more informative when it distinguishes symptom severity, frequency, distress, and interference rather than treating symptoms as a single score. Severity describes how intense a symptom is, while distress reflects how troubling it feels and interference captures effects on activities or function. This multidimensional view helps clinicians identify which problems most need attention.
Looking at multiple symptoms together can reveal a broader clinical pattern than reviewing each complaint in isolation. A symptom cluster approach recognizes that patients may experience several concurrent problems and allows the assessment to represent their combined effects. This is especially relevant when the overall experience, rather than one symptom alone, shapes function, well-being, or quality of life.
Symptom burden can add information that diagnosis and laboratory results may not show. Two people with the same diagnosis or similar test findings may report different levels of distress or interference in daily life, and those differences can matter for care. Patient-reported outcomes therefore keep the patient’s experienced effects visible alongside clinical data.
An assessment commonly begins with a symptom inventory or patient-reported outcome measure, followed by recording severity, frequency, distress, and interference. Repeating the evaluation creates a time-based record instead of a single snapshot. Clinicians can then compare symptom patterns across visits and recognize whether the patient’s experience is changing during illness or treatment.
Repeated symptom burden assessments can support individualized care by showing which reported problems are most disruptive to a person’s daily life. The findings also give clinicians a structured basis for discussing symptoms with patients, rather than relying only on diagnosis or laboratory results. This can improve communication and help focus symptom-management decisions on patient priorities.
In clinical research, tracking symptom burden over time helps evaluate treatment effects from the patient’s perspective. Changes in reported severity, frequency, distress, or interference can complement other study outcomes and show whether an intervention alters everyday experience. This supports research centered on patient-reported outcomes, where meaningful benefit includes effects on function, well-being, and quality of life.